Stock Events

Stock Events

Aclaris Therapeutics (ACRS) Q3 2024 Earnings

7AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.48

-0.37

-0.26

-0.15

Details

Expected EPS

-0.2047

Actual EPS

-0.15

Surprise EPS

0.05

Surprise Percent

+26.72%

Description

Aclaris Therapeutics (ACRS) has reported earnings of -0.15 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.